Lifecore Biomedical, Inc. De (LFCR) Q3 2022 Earnings Call

Concluded Apr 5, 2022

Apr 5, 2022 0 turns

Revenue $35.23M +26.7% YoY

Diluted EPS -$0.46

Gross margin 33.0% -6.3 pp YoY

Net income -$13.59M

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Forward guidance

4 guided metrics

Management's latest ranges and targets are included below.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Apr 5, 2022 10-Q report Filed Apr 7, 2022

From the 8-K filed Apr 5, 2022.

Metric	Period	Guided	Basis
Pro forma consolidated full year fiscal 2022	full year fiscal 2022	$179M – $185M	Non-GAAP
Lifecore segment full year fiscal 2022	full year fiscal 2022	$105M – $108M	—
Pro forma consolidated full year fiscal 2022	full year fiscal 2022	$20.5M – $23M	Non-GAAP
Lifecore segment full year fiscal 2022	full year fiscal 2022	$26M – $27M	Non-GAAP

How the reported period landed and where the business moved.

Switzerland$8.20M +412.5% YoY

All Other Countries$3.70M -5.1% YoY

All Other Countries$1.60M

United Kingdom$900,000 -25% YoY

Czechia$700,000 -12.5% YoY

Ireland$500,000 +66.7% YoY

Canada$200,000 -92.6% YoY

Australia$0